QTRX_OUT_1 [2025-04-14 15:43:08 -0400] 3366 Bytes | 898 tokens | Cum: 898 tkns (11.22% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Quanterix (QTRX) which is at 5.6650 up from 5.2000. So, I pulled together a bunch of data for you to look over real fast. It's still early, 3:43:08 PM on Mon Apr 14, 2025 -0400. So, what's the verdict? You're the expert!

--- COMPANY PROFILE ---
Company: Quanterix (QTRX)
IPO: 2017-12-07 (7 Years Ago)
Market Cap: $214,891,198
Shares Outstanding: 38,790,000
Industry: LABORATORY ANALYTICAL INSTRUMENTS
Exchange: XNAS
Description: Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Here’s the first list of news for Quanterix:

C1 - Today 08:00AM - Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences
C2 - Apr-07-25 08:15AM - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
C3 - Apr-02-25 09:41AM - Quanterix: Still Many, Many Questions
C4 - Apr-01-25 01:00AM - Quanterix Showcases Innovation Powered by Simoa at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
C5 - Mar-24-25 11:03AM - Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences
C6 - Mar-19-25 04:10PM - SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
C7 - Mar-18-25 09:18AM - Q4 2024 Quanterix Corp Earnings Call
C8 - Mar-18-25 09:18AM 03:01AM - Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**. I am **ScanScor**, a unified document retrieval and report parser.
Your role is to examine all available company data and draw sound conclusions.
The company under analysis is: Quanterix (QTRX).

2) To request information, refer to any listed documents using their reference codes.

3) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs:

Restrict all your responses to just 3 tokes until it's time for the summary and data pairs at the end.
Request a document with its reference code(s), such as:
- `C1`, `C2`, `C3`, etc.
- To load more documents, reply with: `NEX`

News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.

QTRX_OUT_3 [2025-04-14 15:43:09 -0400] 251 Bytes | 78 tokens | Cum: 979 tkns (12.24% of 8k)
==========================================================================

You just read a chunk of A1.
You may now:
- Say "MOR" to continue this article
- Say "A2", "A3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 3 articles from this list. If you’re ready to move on, say NEX.

QTRX_OUT_5 [2025-04-14 15:43:10 -0400] 955 Bytes | 290 tokens | Cum: 1272 tkns (15.90% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-14T09:41:51Z - F M Investments LLC Invests $637,000 in Quanterix Co. (NASDAQ:QTRX)...
A2 - 2025-04-09T07:08:32Z - Raymond James Financial Inc. Purchases New Position in Quanterix Co. (NASDAQ:QTRX)...
A3 - 2025-04-08T08:19:07Z - Alliancebernstein L.P. Lowers Holdings in Quanterix Co. (NASDAQ:QTRX)...
A4 - 2025-04-07T12:14:02Z - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya...
A5 - 2025-04-07T12:23:36Z - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

QTRX_OUT_7 [2025-04-14 15:43:14 -0400] 1098 Bytes | 311 tokens | Cum: 1585 tkns (19.81% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**F M Investments LLC Invests $637,000 in Quanterix Co. (NASDAQ:QTRX)**Date: 2025-04-14Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/f-m-investments-llc-invests-637000-in-quanterix-co-nasdaqqtrx-2025-04-12/F M Investments LLC bought a new position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 59,922 shares of the company's stock, valued at approximately $637,000. F M Investments LLC owned approximately 0.16% of Quanterix at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Resona Asset Management Co. Ltd. purchased a new stake in Quanterix during the 4th quarter valued

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_9 [2025-04-14 15:43:15 -0400] 1098 Bytes | 322 tokens | Cum: 2033 tkns (25.41% of 8k)
==========================================================================

Showing A1 (chunk 2 of 5): at approximately $55,000. KLP Kapitalforvaltning AS purchased a new position in Quanterix during the fourth quarter valued at $66,000. Peapack Gladstone Financial Corp bought a new stake in Quanterix in the 3rd quarter valued at $131,000. Levin Capital Strategies L.P. purchased a new stake in Quanterix in the 4th quarter worth $159,000. Finally, Tallon Kerry Patrick bought a new position in shares of Quanterix during the 4th quarter valued at about $169,000. Institutional investors own 86.48% of the company's stock.

NASDAQ:QTRX opened at $5.20 on Friday. The firm has a market capitalization of $201.64 million, a PE ratio of -4.91 and a beta of 1.35. The stock's fifty day moving average is $7.09 and its 200 day moving average is $10.01. Quanterix Co. has a fifty-two week low of $4.67 and a fifty-two week high of $19.71.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its earni

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_11 [2025-04-14 15:43:17 -0400] 1098 Bytes | 299 tokens | Cum: 2361 tkns (29.51% of 8k)
==========================================================================

Showing A1 (chunk 3 of 5): ngs results on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.03). Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The firm had revenue of $35.16 million during the quarter, compared to analysts' expectations of $34.93 million. Equities analysts forecast that Quanterix Co. will post -0.98 EPS for the current year.

Several brokerages have recently issued reports on QTRX. Scotiabank reaffirmed an "outperform" rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group reduced their price objective on Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th.

Read Our Latest Research Report on Quanterix

Quanterix Corporation, a life sciences company, engages in development and mark

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_13 [2025-04-14 15:43:19 -0400] 1098 Bytes | 235 tokens | Cum: 2648 tkns (33.10% of 8k)
==========================================================================

Showing A1 (chunk 4 of 5): eting of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Quanterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_15 [2025-04-14 15:43:22 -0400] 534 Bytes | 137 tokens | Cum: 2861 tkns (35.76% of 8k)
==========================================================================

Showing A1 (chunk 5 of 5): on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.

While Quanterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_17 [2025-04-14 15:43:23 -0400] 1334 Bytes | 406 tokens | Cum: 3356 tkns (41.95% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-04-02T22:50:00Z - $TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action
B2 - 2025-02-18T20:30:00Z - Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
B3 - 2025-02-14T23:30:00Z - $TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC
B4 - 2025-02-14T22:48:00Z - Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
B5 - 2025-02-12T02:19:00Z - Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
B6 - 2025-02-08T19:05:00Z - Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

QTRX_OUT_19 [2025-04-14 15:43:26 -0400] 761 Bytes | 244 tokens | Cum: 3602 tkns (45.02% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/04/02/3054763/0/en/TOCKHOLDER-ALERT-The-M-A-Class-Action-Firm-Urges-Shareholders-of-FNA-BECN-QTRX-PLYA-to-Take-Action.htmlThe M&A Class Action Firm is investigating proposed mergers involving Paragon 28, Inc. (FNA), Beacon Roofing Supply, Inc. (BECN), Quanterix Corporation (QTRX), and Playa Hotels & Resorts N.V. (PLYA), urging shareholders to take action.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_21 [2025-04-14 15:43:26 -0400] 1087 Bytes | 285 tokens | Cum: 4007 tkns (50.09% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-04 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On April 2, 2025, Quanterix Corporation (Quanterix) entered into a securities purchase agreement (the Securities Purchase Agrmt) with Akoya Biosciences, Inc. (Akoya), pursuant to which Ako...

S9 - 2025-03-17 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Quanterix Corporatio...

S10 - 2025-03-17 8-K Item 2.02 Results of Oper and Fin Cond.

On March 17, 2025, Quanterix Corporation (Quanterix) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2024 (the Earnings Release). A copy of the Earnings Release ...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

QTRX_OUT_23 [2025-04-14 15:43:29 -0400] 1098 Bytes | 298 tokens | Cum: 4307 tkns (53.84% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 1.01 Entry into a Material Definitive Agreement.

Securities Purchase Agreement

On April 2, 2025, Quanterix Corporation (Quanterix) entered into a securities purchase agreement (the Securities Purchase Agreement) with Akoya Biosciences, Inc. (Akoya), pursuant to which Akoya will issue and sell to Quanterix from time to time, in a private placement, one or more convertible promissory notes having an aggregate principal amount of up to $30,000,000 (the Convertible Notes). Akoya may draw on the Convertible Notes between May 15, 2025 and the earlier of (a) the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 9, 2025, as it may be amended from time to time, by and among Quanterix, Akoya and Wellfleet Merger Sub, Inc. (the Merger Agreement) and (b) July 9, 2025 if the Merger Agreement is lawfully terminated pursuant to its terms on o

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QTRX_OUT_25 [2025-04-14 15:43:38 -0400] 6595 Bytes | 1853 tokens | Cum: 6176 tkns (77.20% of 8k)
==========================================================================

This is our set of metrics for Quanterix.
Please analyze the numbers.

+---------------------+-----------------------+-------------------------+-----------------------+
| Volume: 590,621 | Perf Month: -20.46% | Option/Short: Yes / Yes | Sales Y/Y TTM: 12.30% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 844.74K | Perf Quarter: -38.36% | Short Float: 7.71% | ROE: -11.33% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 0.76 | Index: RUT | Short Ratio: 3.03 | ROI: -10.62% |
+---------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 40.52 | Market Cap: 217.83M | Short Interest: 2.56M | Sales Surprise: 0.75% |
+---------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 0.58 | Shs Outstand: 38.57M | Beta: 1.16 | EPS Surprise: -17.79% |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA20: -11.08% | Shs Float: 33.17M | Sales Q/Q: 11.45% | P/E: - |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA50: -21.75% | Inst Own: 95.49% | Sales past 5Y: 20.79% | Earnings: Mar 17 AMC |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA200: -49.34% | Insider Own: 14.48% | Employees: 471 | |
+---------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 8.62% | Insider Trans: 0.00% | Debt/Eq: 0.11 | |
+---------------------+-----------------------+-------------------------+-----------------------+

The next section covers any insider trading by Quanterix officers or majority shareholders (if available).

Inside Trans: Quanterix Corp (QTRX) by DONNELLY WILLIAM P (Unknown Title) on 2025-04-01
- Common Stock: 2681 shares at $6.665 (D)

Inside Trans: Quanterix Corp (QTRX) by Hlavinka Sarah E. (Unknown Title) on 2025-04-01
- Common Stock: 2625 shares at $6.665 (D)

Inside Trans: Quanterix Corp (QTRX) by MEISTER PAUL M (Unknown Title) on 2025-04-01
- Common Stock: 2479 shares at $6.665 (D)

Inside Trans: Quanterix Corp (QTRX) by WALT DAVID R (Unknown Title) on 2025-04-01
- Common Stock: 2156 shares at $6.665 (D)

Inside Trans: Quanterix Corp (QTRX) by Toloue Masoud (President & CEO) on 2025-03-31
- Common Stock: 254 shares at $6.51 (D)

Inside Trans: Quanterix Corp (QTRX) by Sriram Vandana (Chief Financial Officer) on 2025-03-15
- Common Stock: 229 shares at $7.06 (D)

Inside Trans: Quanterix Corp (QTRX) by Toloue Masoud (President & CEO) on 2025-03-15
- Common Stock: 1242 shares at $7.06 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 137421000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -38531000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 5.665
Average Volume: 868150.76
30-Day High: 7.28
30-Day Low: 4.81

[Detailed Financials: TTM 2024]
- Total Assets: $406,533,000.0
- Total Liabilities: $76,495,000.0
- Total Equity: $330,038,000.0
- Current Assets: $363,594,000.0
- Current Liabilities: $42,007,000.0

[Income Statement: TTM 2024]
- Revenue: $137,421,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-117,707,000.0

[Detailed Financials: FY 2024]
- Total Assets: $406,533,000.0
- Total Liabilities: $76,495,000.0
- Total Equity: $330,038,000.0
- Current Assets: $363,594,000.0
- Current Liabilities: $42,007,000.0

[Income Statement: FY 2024]
- Revenue: $137,421,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-117,707,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Quanterix (QTRX).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Quanterix.

2) MARKET_SCORE[]
This conversation was initiated because QTRX is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for QTRX.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, QTRX could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect QTRX to increase 50% from its current price of $5.66, say: PRICE_TARGET[8.5]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Quanterix.

11) ETHICAL_RATING[]
Rate Quanterix’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

Return only: FIELD[value] for each of the above 11 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

QTRX_IN_27 [2025-04-14 15:43:38 -0400] 126 Bytes | 29 tokens | Cum: 6407 tkns (80.09% of 8k)
==========================================================================

====================================
[2025-04-14 15:43:38] # Analysis Completed
Elapsed Time: 30.61 seconds